We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$670M
AUM Growth
-$18.2M
Cap. Flow
-$335M
Cap. Flow %
-50.06%
Top 10 Hldgs %
86.43%
Holding
215
New
27
Increased
46
Reduced
57
Closed
68

Top Buys

Rank Stock Value
1
NRXP icon
NRX Pharmaceuticals
NRXP
+$2.55M
2
TANH icon
Tantech Holdings
TANH
+$2.26M
3
AGTC
Applied Genetic Technologies Corporation
AGTC
+$1.76M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$1.52M
5
NBEV
NewAge, Inc. Common Stock (Delaware)
NBEV
+$1.12M

Top Sells

Rank Stock Value
1
BTBT icon
Bit Digital
BTBT
+$17.7M
2
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$10.2M
3
ROI
RiskOn International, Inc. Common Stock
ROI
+$7.16M
4
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$5.75M
5
SLAI
SOLAI Ltd ADS
SLAI
+$5.55M

Sector Composition

Rank Sector Weight
1 Healthcare 7.59%
2 Technology 1.45%
3 Financials 0.54%
4 Consumer Discretionary 0.53%
5 Consumer Staples 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CING icon
26
Cingulate
CING
$61M
$1.49M 0.22%
3,142
-551
-15% -$243K
LSTA icon
27
Lisata Therapeutics
LSTA
$10.6M
$1.48M 0.22%
158,102
+50,974
+48% +$583K
LFWD icon
28
ReWalk Robotics
LFWD
$19.6M
$1.47M 0.22%
15,132
+2,844
+23% +$268K
ATOS icon
29
PUT
Atossa Therapeutics
ATOS
$24.1M
$1.43M 0.21%
763
-62
-8% -$1.26K
AFIB
30
DELISTED
Acutus Medical Inc
AFIB
$1.42M 0.21%
1,018,950
+273,350
+37% +$584K
ANY icon
31
PUT
Sphere 3D
ANY
$16.8M
$1.34M 0.2%
91
-33
-27% -$5.37K
VINC
32
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$1.31M 0.2%
16,362
+3,418
+26% +$422K
ZVRA icon
33
Zevra Therapeutics
ZVRA
$575M
$1.3M 0.19%
258,780
+238,780
+1,194% +$1.52M
BTBT icon
34
PUT
Bit Digital
BTBT
$459M
$1.23M 0.18%
3,422
-7,561
-69% -$31.8K
CHRN
35
ChronoScale Holdings
CHRN
$2.94B
$1.15M 0.17%
26,587
-6,662
-20% -$261K
KNDI
36
PUT
Kandi Technologies Group
KNDI
$63.5M
$1.13M 0.17%
3,524
-2,497
-41% -$7.94K
USWS
37
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$1.07M 0.16%
+162,379
New +$1.11M
CORZ
38
CALL
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$1.07M 0.16%
1,296
+182
+16% +$1.61K
AGTC
39
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.04M 0.16%
+970,057
New +$1.76M
SLAI
40
DELISTED
SOLAI Ltd ADS
SLAI
$969K 0.14%
4,961
-23,610
-83% -$5.55M
ANY icon
41
Sphere 3D
ANY
$16.8M
$909K 0.14%
6,183
+3,186
+106% +$518K
GYRE icon
42
Gyre Therapeutics
GYRE
$668M
$871K 0.13%
176,000
+24,222
+16% +$120K
ATNM icon
43
CALL
Actinium Pharmaceuticals
ATNM
$27.2M
$868K 0.13%
1,699
+301
+22% +$1.58K
KNDI
44
Kandi Technologies Group
KNDI
$63.5M
$858K 0.13%
268,052
-135,672
-34% -$431K
ASLN
45
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$839K 0.13%
23,310
+814
+4% +$30.3K
CRIS icon
46
Curis
CRIS
$9.41M
$823K 0.12%
865
+299
+53% +$382K
ATHX
47
DELISTED
Athersys, Inc. Common Stock
ATHX
$816K 0.12%
11,658
+7,000
+150% +$146K
SPI
48
PUT
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$796K 0.12%
2,774
-214
-7% -$685
BEAT icon
49
Heartbeam
BEAT
$29.3M
$762K 0.11%
413,089
-70,231
-15% -$153K
ATNM icon
50
PUT
Actinium Pharmaceuticals
ATNM
$27.2M
$752K 0.11%
1,471
-2,530
-63% -$13.3K
1
2
3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2022 Portfolio in Review

As of Q1 2022, Sabby Management held 215 positions worth $670M, down 2.6% from $688M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Sabby Management withdrew a net $335M in Q1 2022, closing 68 positions and reducing 57 holdings. Its most notable exit was Bit Digital, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 7.4% a quarter earlier, followed by Technology and Financials.

Against the trend, Sabby Management opened a new position in NRX Pharmaceuticals worth $1.92M.

  • Sabby Management's largest Q1 2022 buy was NRX Pharmaceuticals: 78,247 shares worth $1.92M.
  • Sabby Management added most to Tantech Holdings in Q1 2022, an estimated $2.26M increase.
  • Sabby Management's biggest Q1 2022 reduction was SOLAI Ltd ADS, cutting an estimated $5.55M.
  • Sabby Management fully exited Bit Digital in Q1 2022, selling an estimated $17.7M.
  • Sabby Management's ten largest holdings make up 86% of its $670M portfolio in Q1 2022.
  • Sabby Management opened 27 new positions and closed 68 in Q1 2022.
  • Sabby Management's portfolio value fell 2.6% quarter-over-quarter to $670M.

Based on Sabby Management's 13F filing for Q1 2022, filed 16 May 2022.